Table 2.
Comparison of preoperative risk factors for postoperative death within 1 year after RARC
| Variables | Death within 1 year (31) | Death after 1 year (155) | P value |
|---|---|---|---|
| Age, years, median (IQR) | 69 (51‐86) | 63 (32‐83) | <0.001 |
| Gender, n (%) | |||
| Male | 26 (83.9) | 131 (84.5) | 1.000 |
| Female | 5 (16.1) | 24 (15.5) | |
| BMI, kg/m2 | 23.31 (18‐32) | 25.10 (16‐45) | 0.070 |
| ASA score ≥3, n (%) | 6 (19.4) | 20 (12.9) | 0.499 |
| No. of tumors, n (%) | |||
| Solitary | 20 (64.5) | 78 (50.3) | 0.171 |
| Multiple | 11 (35.5) | 77 (49.7) | |
| Clinical stage, n (%) | |||
| ≤T1 | 2 (6.5) | 37 (23.9) | 0.001 |
| T2 | 20 (64.5) | 105 (67.7) | |
| ≥T3 | 9 (29.0) | 13(8.4) | |
| Pathological type, n (%) | |||
| UC | 30 (96.8) | 146 (94.2) | 1.000 |
| NUC | 1 (3.2) | 9 (5.8) | |
| Pathological grade, n (%) | |||
| PUNLMP | 0 (0.0) | 8 (5.9) | 0.338 |
| LGPUC | 8 (33.3) | 54 (39.7) | |
| HGPUC | 16 (66.7) | 74 (54.4) | |
| Hydronephrosis, n (%) | |||
| Absent | 18 (58.1) | 119 (76.8) | 0.068 |
| Unilateral | 8 (25.8) | 26 (16.8) | |
| Bilateral | 5 (16.1) | 10 (6.5) | |
| Fibrinogen, n (%) | |||
| <3.295 | 11 (36.7) | 95 (63.8) | 0.008 |
| ≥3.295 | 19 (63.3) | 54 (36.2) | |
| NLR, n (%) | |||
| <1.4388 | 0 (0.0) | 24 (15.5) | 0.016 |
| ≥1.4388 | 31 (100.0) | 131 (84.5) | |
| PLR, n (%) | |||
| <111 | 5 (16.1) | 58 (37.4) | 0.023 |
| ≥111 | 26 (83.9) | 97 (62.6) | |
| LMR, n (%) | |||
| <3.4974 | 2 (6.5) | 14 (9.0) | 1.000 |
| ≥3.4974 | 29 (93.5) | 141 (91.0) | |
| AGR, n (%) | |||
| <1.5262 | 28 (90.3) | 134 (86.5) | 0.771 |
| ≥1.5262 | 3 (9.7) | 21 (13.5) | |
| PNI, n (%) | |||
| <50.95 | 25 (80.6) | 87 (56.1) | 0.015 |
| ≥50.95 | 6 (19.4) | 68 (43.9) | |
Abbreviations: AGR, albumin‐globulin ratio; ASA, American Society of Anesthesiologists; BMI, body mass index; HGPUC, high‐grade papillary urothelial carcinoma; IQR, interquartile range; LGPUC, low‐grade papillary urothelial carcinoma; LMR, lymphocyte‐monocyte ratio; NLR, neutrophil‐lymphocyte ratio; NUC, non‐urothelial carcinoma; PLR, platelet‐lymphocyte ratio; PNI, prognostic nutritional index; PUNLMP, papillary urothelial neoplasm of low malignant potential; UC, urothelial carcinoma.